Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Bone Marrow Transplantation

Volumn 37, Issue 4, 2006, Pages 403-409

  Grazziutti, M L ^a   Dong, L ^a   Miceli, M H ^a   Cottler Fox, M ^b   Krishna, S G ^a   Fassas, A ^a   van Rhee, F ^a   Barlogie, B M ^a   Anaissie, Elias J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Autologous stem cell transplant; Bone marrow engraftment; Immature reticulocyte fraction; Neutropenia

Indexed keywords

BORTEZOMIB; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; HEMOGLOBIN; MELPHALAN; PHOSPHATE; RITUXIMAB; THALIDOMIDE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL MATURATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; ERYTHROID CELL; HUMAN; HYPOPHOSPHATEMIA; INFECTION RISK; MAJOR CLINICAL STUDY; MONOCYTE; MULTIPLE MYELOMA; NEUTROPENIA; NEUTROPHIL COUNT; PHOSPHATE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RETICULOCYTE; UNITED STATES; VALIDATION PROCESS;

COHORT STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KINETICS; MULTIPLE MYELOMA; NEUTROPENIA; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETICULOCYTE COUNT; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 32844472529     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705251     Document Type: Article

References (25)

1. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079-1087.
2. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Predicting the risk of bacteremia in childen with fever and neutropenia. J Clin Oncol 1996; 14: 919-924.
3. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. 'Low-risk' prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000; 18: 1012-1019.
4. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751.
5. Akpek G, Knight RD, Wright DG. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy. Am J Hematol 2003; 72: 13-19.
6. Raanani P, Levi I, Holzman F, Grotto I, Brok-Simoni F, Avigdor A et al. Engrafment-associated hypophosphatemia - the role of cytokine release and steep leukocyte rise post stem cell transplantation. Bone Marrow Transplant 2001; 27: 311-317.
7. Uckan D, Cetin M, Dida A, Batu A, Tuncer M, Tezcan I. Hypophosphatemia and hypouricemia in pediatric allogeneic bone marrow transplant recipients. Pediatr Transplant 2003; 7: 98-101.
8. Davis BH, Bigelow NC. Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index. Arch Pathol Lab Med 1989; 113: 684-689.
9. Lacombe F, Lacoste L, Vial JP, Briais A, Reiffers J, Boisseau MR et al. Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol 1999; 112: 677-686.
10. Davis BH, Bigelow N, Ball ED, Mills L, Cornwell III GG. Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation. Am J Hematol 1989; 32: 81-87.
11. Davis BH. Immature reticulocyte fraction (IRF): By any name, a useful clinical parameter of erythropoietic activity. Lab Hematol 1996; 2: 2-8.
12. Chang CC, Kass L. Clinical significance of immature reticulocyte fraction determined by automated reticulocyte counting. Am J Clin Pathol 1997; 108: 69-73.
13. Shaughnessy Jr J, Tian E, Sawyer J, McCoy J, Tricot G, Jacobson J et al. Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: Early results of total therapy II. Br J Haematol 2003; 120: 44-52.
14. Martin A, Perez-Simon JA, Caballero MD, Lopez-Holgado N, Vazquez L, del Canizo MC et al. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma. Haematologica 2005; 90: 78-85.
15. Dalal BI, Stockford GR, Naiman SC, Spinelli JJ, Phillips GL. Criteria for marrow engraftment: Comparison of reticulocyte maturity index with conventional parameters. Bone Marrow Transplant 1996; 17: 91-92.
16. Noronha JF, De Souza CA, Vigorito AC, Aranha FJ, Zulli R, Miranda EC et al. Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clin Lab Haematol 2003; 25: 47-54.
17. Greinix HT, Linkesch W, Keil F, Kalhs P, Schwarzinger I, Schneider B et al. Early detection of hematopoietic engraftment after bone marrow and peripheral blood stem cell transplantation by highly fluorescent reticulocyte counts. Bone Marrow Transplant 1994; 14: 307-313.
18. Davies SV, Cavill I, Bentley N, Fegan CD, Poynton CH, Whittaker JA. Evaluation of erythropoiesis after bone marrow transplantation: quantitative reticulocyte counting. Br J Haematol 1992; 81: 12-17.
19. Spanish Multicentric Study Group for Hematopoietic Recovery. Flow cytometric reticulocyte quantification in the evaluation of hematologic recovery. Eur J Haematol 1994; 53: 293-297.
20. Grotto HZ, Vigoritto AC, Noronha JF, Lima GA. Immature reticulocyte fraction as a criterion for marrow engraftment. Evaluation of a semi-automated reticulocyte counting method. Clin Lab Haematol 1999; 21: 285-287.
21. Torres A, Sanchez J, Lakomsky D, Serrano J, Alvarez MA, Martin C et al. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica 2001; 86: 24-29.
22. Sica S, Salutari P, Laurenti L, Ortu La Barbera E, Zini G, d'Onofrio G et al. Highly fluorescent reticulocytes after CD34+ peripheral blood progenitor cell transplantation. Bone Marrow Transplant 1998; 21: 361-364.
23. Buttarello M, Bulian P, Farina G, Petris MG, Temporin V, Toffolo L. Five fully automated methods for performing immature reticulocyte fraction: comparison in diagnosis of bone marrow aplasia. Am J Clin Pathol 2002; 117: 871-879.
24. Marr KA. Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39 (Suppl 4): S170-S175.
25. Mahfouz T, Anaissie E. Prevention of fungal infections in the immunocompromised host. Curr Opin Invest Drugs 2003; 4: 974-990.